Carlsmed, Inc. (NASDAQ:CARL) — Market Cap & Net Worth
Market Cap & Net Worth: Carlsmed, Inc. (CARL)
Carlsmed, Inc. (NASDAQ:CARL) has a market capitalization of $409.27 Million ($409.27 Million) as of September 17, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #13348 globally and #3246 in its home market, demonstrating a -2.37% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Carlsmed, Inc.'s stock price $15.23 by its total outstanding shares 27302743 (27.30 Million). Also see CARL current and non-current assets for a full breakdown of the balance sheet.
Carlsmed, Inc. Market Cap History: 2025 to 2026
Carlsmed, Inc.'s market capitalization history from 2025 to 2026. Data shows growth from $337.19 Million to $415.82 Million (0.00% CAGR). Also see Carlsmed, Inc. (CARL) cash flow conversion for how efficiently the company converts equity into cash flow.
Carlsmed, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Carlsmed, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check CARL share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
6.68x
Carlsmed, Inc.'s market cap is 6.68 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $337.19 Million | $50.51 Million | -$29.63 Million | 6.68x | N/A |
Competitor Companies of CARL by Market Capitalization
Companies near Carlsmed, Inc. in the global market cap rankings as of September 17, 2026. Review CARL intangible-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Carlsmed, Inc. by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #738 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1902 globally with a market cap of $12.23 Billion USD ( AU$17.28 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2076 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2133 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #738 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $266.62 |
| #1902 | Pro Medicus Ltd | AU:PME | $12.23 Billion | AU$165.45 |
| #2076 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $68.85 |
| #2133 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $58.84 |
Carlsmed, Inc. Historical Marketcap From 2025 to 2026
Between 2025 and today, Carlsmed, Inc.'s market cap moved from $337.19 Million to $ 415.82 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $415.82 Million | +23.32% |
| 2025 | $337.19 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Carlsmed, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $409.27 Million USD |
| MoneyControl | $409.27 Million USD |
| MarketWatch | $409.27 Million USD |
| marketcap.company | $409.27 Million USD |
| Reuters | $409.27 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Carlsmed, Inc.
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and … Read more